tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
PremiumRatingsPromising Phase 2b Results and Competitive Positioning Support Buy Rating for Abivax’s Obefazimod
20d ago
Abivax price target raised to $114 from $95 at Citizens JMP
Premium
The Fly
Abivax price target raised to $114 from $95 at Citizens JMP
24d ago
One new option listing on September 18th
Premium
The Fly
One new option listing on September 18th
1M ago
Abivax prices 10.2M ADSs at $64.00 in underwritten public offering
PremiumThe FlyAbivax prices 10.2M ADSs at $64.00 in underwritten public offering
3M ago
Abivax 10.16M ADS offering priced at $64.00
Premium
The Fly
Abivax 10.16M ADS offering priced at $64.00
3M ago
Abivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
Premium
Ratings
Abivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
3M ago
Abivax price target raised to $101 from $45 at LifeSci Capital
PremiumThe FlyAbivax price target raised to $101 from $45 at LifeSci Capital
3M ago
Abivax upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Abivax upgraded to Overweight from Equal Weight at Morgan Stanley
3M ago
Abivax upgraded to Overweight at Morgan Stanley after obefazimod data
Premium
The Fly
Abivax upgraded to Overweight at Morgan Stanley after obefazimod data
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100